Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
Holding DYN?
Track your performance easily

Dyne Therapeutics (DYN) Ownership - Who Owns Dyne Therapeutics?

292 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 15, 2024
Dirk Kersten
Director
xxxxxxxxxxxxx
$293050
Sep 10, 2024
Richard William Scalzo
Svp, Head Of Finance & Admin
xxxxxxxxxxxxx
$4052851
Sep 04, 2024
John Cox
Ceo & President,director
xxxxxxxxxxxxx
$1057216
Mar 13, 2024
xxxxxxxxxxxxx
$725344

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,562,578Insider6.45%186,311,589
6,545,479Insider6.43%185,826,149
6,295,412Institution6.19%178,726,747
6,049,204Institution5.94%171,736,902
5,786,435Insider5.69%164,276,890
3,831,223Institution3.76%108,768,421
3,732,065Institution3.67%105,953,325
2,306,079Insider2.27%65,469,583
2,161,084Institution2.12%61,353,175
2,102,835Institution2.07%59,699,486

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,732,065Institution3.67%105,953,325
2,161,084Institution2.12%61,353,175
2,102,835Institution2.07%59,699,486
1,201,670Institution1.18%34,115,411
1,196,034Institution1.18%33,955,405
963,634Institution0.95%27,357,569
915,468Institution0.90%25,990,137
892,923Institution0.88%25,350,084
766,720Institution0.75%21,767,181
662,251Institution0.65%18,801,306

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,652,912Institution2.61%95,292,599
2,283,327Institution2.24%64,823,654
1,897,390Institution1.86%57,509,891
1,173,443Institution1.15%42,150,073
1,069,628Institution1.05%38,421,038
723,755Institution0.71%25,997,280
728,657Institution0.72%20,686,572
510,856Institution0.50%14,503,202
370,087Institution0.36%13,293,525
378,666Institution0.37%11,477,366

FAQ

Who Owns Dyne Therapeutics (DYN)?
Currently, no data Available
What percentage of Dyne Therapeutics (DYN) stock is held by institutional investors?
Currently, no data Available
What percentage of Dyne Therapeutics (DYN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Dyne Therapeutics (DYN)?
Atlas Venture Fund XI, L.P. owns the most shares of Dyne Therapeutics (DYN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis